🔎 Trials Near Me

Akèy › Limfòm selil-T perifèrik › Michigan › Ann Arbor

Etid klinik pou Limfòm selil-T perifèrik nan Ann Arbor, MI

3 etid pou Limfòm selil-T perifèrik ap chèche patisipan nan sit nan ak bò kote Ann Arbor (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Ap rekriteFaz 3
  • Roger Cancer Center University of Michigan Health, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06561048

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Ap rekriteFaz 1
  • University of Michigan, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07195916

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Ap rekriteFaz 1
  • University of Michigan, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2025 · NCT04234048

Etid Limfòm selil-T perifèrik nan lòt vil

Lòt etid nan Ann Arbor

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.